Laser and innovation
Investor relations
Governance
Sustainability
Work with us
Contacts
Browse our interactive chart
The 2023 financial year closed with consolidated revenues of approximately 692 million of euro, an increase of approximately 3% compared to 2022, with an EBIT of approximately 73 million of euro, equal to 10.5% of revenues, down compared to 81 million in the previous year, and a Group net Income of 48,2 million of euro. In the fourth quarter of 2023, record sales approached the 200 million of euro threshold (199,2 million), an increase of 5.3 % compared to the fourth quarter of 2022, with an income from operations equal to 21 million of euro.
In 2022, turnover grew by 18% to over EUR 673 million, confirming the Group’s strong competitive positioning and its great ability to differentiate itself in the markets through technical and application innovations.
EBITDA was EUR 95.3 million, up 18.9% from EUR 80.1 million as at 31 December 2021 due to the increase in turnover and better absorption of structural costs. The impact on turnover has improved marginally (14% in 2021, 14.1% in 2022).
The financial year 2022 showed a net result for the Group of EUR 55 million, the best ever recorded by the group.
150 million €
145 million €
379 million €
392 million euros
medical turnover in millions €:
300 million euros
industrial turnover in millions €: